Last mentioned: Jul 7, 2026
Across the most recent 3 stories covering President Trump — 33% negative, 67% neutral sentiment, averaging 7/10 impact.
This entity profile aggregates every story where the entity meets our minimum relevance threshold before it is linked here — a story naming this entity only in passing, as competitive context for an unrelated subject, does not qualify. That threshold exists because earlier testing surfaced entity pages cluttered with tangential mentions: a story about two unrelated companies merging could otherwise populate a third company's page simply because it was named once for comparison, with no real event of its own. The timeline below reflects genuine milestones and developments specific to this entity, cross-referenced against the same source-verification standard applied to every story on this site. Sentiment measures the directional read of each development for this entity specifically, not the overall tone of the reporting, and impact weights how consequential a development is rather than how widely it was syndicated across outlets.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived. See something wrong on this page? Report a data issue.
OFAC license revoked
The U.S. Treasury announces immediate revocation of the authorization that allowed Iranian oil production, delivery, and sale through August 21, 2026.
Tanker attacks in Strait of Hormuz
Multiple commercial vessels attacked in the strategic waterway, heightening security risks and prompting international condemnation.
Fed Meeting Starts Under Warsh
New Chairman Kevin Warsh presides over his first Federal Open Market Committee meeting; rate decision expected June 17.
100 Days of War; G7 Summit
The war reaches 100 days. US President Trump attends G7 summit in France, with peace negotiations as a central agenda item.
Iran War Begins
Conflict erupts, immediately impacting global energy markets and prompting defense posture reviews worldwide.
TrumpRx, the Trump administration's drug discount website, has secured voluntary pricing deals on only 92 brand-name drugs—less than 12% of the 800-plus products from 17 major pharmaceutical companies. High-cost therapies for inflammatory diseases, HIV, and cancer are largely excluded, raising doubts about industry's willingness to compromise on pricing without legislation.
The U.S. Treasury’s sudden revocation of the Iran oil sales license after Hormuz attacks puts tanker routes on high alert, threatening just-in-time crude deliveries and raising logistics costs across global supply chains.
As the Iran war passes 100 days, central banks controlling 40% of world GDP are hitting pause, leaving space and defense markets in limbo. The Fed and BOE hold rates, awaiting peace talks, while BoJ diverges with a likely hike. Defense budgets and space investments hang on geopolitical and monetary signals.
Source: economictimes.indiatimes.com · Bloomberg